Evidence map›Paper›PMID 30824630›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies-Response.

Andrew J Bauer, Douglas R Stewart, Junne Kamihara, Anne K Harris, Joyce Turner, Rachana Shah, Kami Wolfe Schneider, Katherine Schneider, Ann Garrity Carr, Laura A Harney and 8 more

Registry-linked trialAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03382158 (International Pleuropulmonary Blastoma/DICER1 Registry), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03382158 recruitingnot on this map

International Pleuropulmonary Blastoma/DICER1 Registry (for PPB, DICER1 and Associated Conditions)

Typeobservational_patient_registrySponsorChildren's Hospitals and Clinics of MinnesotaRan2016 to 2035Enrolled3,400ConditionsPleuropulmonary Blastoma, Sertoli-Leydig Cell Tumor, DICER1 Syndrome, Cystic Nephroma
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. DICER1-Related Tumor Predisposition: Identification of At-risk Individuals and Recommended Surveillance Strategies.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  4. Article
  5. Case - Bilateral and recurrent pediatric cystic nephroma associated with DICER1 mutation.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Andrew J BauerDivision of Endocrinology and Diabetes, Pediatric Thyroid Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Douglas R StewartClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland.
Junne KamiharaPediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
Anne K HarrisInternational Pleuropulmonary Blastoma Registry, Children's Minnesota, Minneapolis, Minnesota.
Joyce TurnerChildren's National Medical Center, Department of Genetics and Metabolism, Rare Disease Institute, Washington, D.C.
Rachana ShahDivision of Hematology, Oncology and Blood and Marrow Transplantation, Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles Keck School of Medicine, University of Southern California, Los Angeles, California.ORCID 0000-0002-8445-2172
Kami Wolfe SchneiderHematology, Oncology, and Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Children's Hospital Colorado, Aurora, Colorado.
Katherine SchneiderDana-Farber Cancer Institute, Center for Cancer Genetics and Prevention, Boston, Massachusetts.
Ann Garrity CarrWestat, Rockville, Maryland.
Laura A HarneyWestat, Rockville, Maryland.
A Lindsay FrazierPediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
Daniel OrbachSIREDO Oncology Center (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, PSL University, Paris, France.ORCID 0000-0002-2520-139X
Dominik T SchneiderClinic of Pediatrics, Municipal Hospital Dortmund, Dortmund, Germany.
David MalkinDivision of Hematology/Oncology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Louis P DehnerDivision of Anatomic Pathology, Lauren V. Ackerman Laboratory of Surgical Pathology, Barnes-Jewish and St. Louis Children's Hospitals, Washington University Medical Center, St. Louis, Missouri.
Yoav H MessingerInternational Pleuropulmonary Blastoma Registry, Children's Minnesota, Minneapolis, Minnesota.
D Ashley HillDepartment of Pathology, Center for Cancer and Immunology Research, Children's National Medical Center, Washington, D.C.ORCID 0000-0003-1067-3922
Kris Ann P SchultzInternational Pleuropulmonary Blastoma Registry, Children's Minnesota, Minneapolis, Minnesota. krisann.schultz@childrensmn.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DEAD-box RNA HelicasesRibonuclease IIIHumansDEAD-box RNA HelicasesDICER1 protein, humanRibonuclease III

Identifiers

PMID30824630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.